Why the study?
Molecular genetic studies have identified multiple genes and mutations associated with familial hypertrophic cardiomyopathy, but further genotype-phenotype correlation studies are needed to clarify their impact on clinical course and prognosis.
Answers are grounded in this paper and cite their sources.
This review summarizes the genetic basis of familial hypertrophic cardiomyopathy, highlighting the role of sarcomeric protein gene mutations and their association with sudden cardiac death risk.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Keller et al. (2002) conducted a review in familial hypertrophic cardiomyopathy. Genetic mutations was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: